Ganeden Biotech® Invests in Consumer Education with Its New GanedenBC30® Website
The new consumer website offers a user-friendly experience with enhanced functionality and education, along with detailed partner product information.
Cleveland, OH (PRWEB) August 15, 2013
Ganeden Biotech, a recognized world leader in the manufacturing and marketing of probiotics, announces the debut of its redesigned website http://www.GanedenBC30.com. The new site features educational, navigational and visual enhancements for a better user experience to help consumers understand probiotics and GanedenBC30.
“At Ganeden, we believe consumer education is fundamental to our partners’ success, our success and to helping more people incorporate probiotics into their daily lives. We are proud of the new consumer website that we designed to achieve this,” said Erin Miller, Marketing Manager.
The transformed website offers visitors a modern user-friendly experience with quick and easy access to its extensive list of partner products, as well as a wealth of new and updated information for guests interested in products containing GanedenBC30. Ganeden Biotech anticipates that the new design will better meet the needs and expectations of consumers looking for information on GanedenBC30 or probiotics in general by delivering a more visually appealing, functional, and informative website.
New website enhancements include:
- New easy-to-navigate layout, with a clean new look that is visually attractive.
- A categorized, easy to use listing that showcases many of the products that contain GanedenBC30; along with product photos and web addresses.
- An abundance of information that aims to educate the consumer on probiotics and on GandenBC30, the science behind it, its benefits, and how it is unique.
- GanedenBC30 news and events; including news releases and media mentions.
- Social Media integration, including quick links to Facebook and Twitter.
- More efficient online contact forms, making it easier to contact Ganeden Biotech, ask a question, or sign up to receive monthly emails.
Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS probiotic ingredient found in more than 60 leading food, beverage and animal health products. GanedenBC30 is a probiotic bacterium. Probiotics are live microorganisms which, when administered in adequate amounts, confer a beneficial health effect on the host. GanedenBC30 is a patented, gram positive, spore-forming, lactic acid producing strain of Bacillus coagulans. GanedenBC30 (Bacillus coagulans GBI-30, 6086) has received a GRAS no-objection letter from the US FDA. Unlike other probiotic strains used in food and beverages, GanedenBC30 is highly stable, can remain viable through processing, shelf life and the low pH of stomach acid has been shown effective in 17 peer reviewed, published papers. GanedenBC30 is shelf stable for up to three years. For more information, please visit GanedenBC30.com.
About Ganeden Biotech:
Founded in 1997 the Cleveland, Ohio-based Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies for the food, beverage, animal health, and now topical ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS probiotic ingredient found in more than 60 leading food and beverage products. A highly stable probiotic ingredient with physical properties that make it more stable than traditional probiotic organisms (such as Lactobacillus and Bifidobacterium); GanedenBC30 is ideally suited for almost any food, beverage or animal health application. Ganeden's newest ingredient, Bonicel, is a patented, probiotic-derived, topical cosmeceutical ingredient shown to dramatically reduce signs of aging. It can easily be incorporated in virtually any lotion, cream, soap, shampoo or other personal care product. Ganeden Biotech takes special care to help manufacturers develop and market probiotic products. For more information about Ganeden Biotech and licensing opportunities, visit GanedenBiotech.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11031183.htm